Literature DB >> 8684160

Difficulties and strategies of HIV diagnosis.

L Gürtler1.   

Abstract

HIV infection is commonly diagnosed by detection of antibodies (anti-HIV) by ELISA or agglutination. Reactive results are confirmed by western blot (immunoblot) or further specific tests such as competitive ELISA, which, when evaluated quantitatively, allow the differentiation of HIV types and partially subtypes. Detection of infection of newborn babies, characterisation of individual strains for subtyping and forensic identification, and therapeutic monitoring are the domain of nucleic-acid-based assays. Nucleic-acid-based assays narrow the serological diagnostic window period in early HIV infection and, when quantified, give some indication of clinical status.

Entities:  

Mesh:

Year:  1996        PMID: 8684160     DOI: 10.1016/s0140-6736(96)01036-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Technology and effect: HIV/AIDS testing in Brazil.

Authors:  J Biehl; D Coutinho; A L Outeiro
Journal:  Cult Med Psychiatry       Date:  2001-03

2.  HIV in Africa: Challenges and Directions for the Next Decade.

Authors:  Bruce L Gilliam; Devang Patel; Rohit Talwani; Zelalem Temesgen
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

3.  Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays.

Authors:  Jesse L Clark; Thomas J Coates; Andres G Lescano; Rosa Castillo; Rina Meza; Franca R Jones; Segundo Leon; Jose Pajuelo; Carlos F Caceres; Jeffrey D Klausner
Journal:  Clin Vaccine Immunol       Date:  2006-02

4.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

5.  Field evaluation of a combination of monospecific enzyme-linked immunosorbent assays for type-specific diagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV-seropositive persons in Abidjan, Ivory Coast.

Authors:  J N Nkengasong; C Maurice; S Koblavi; M Kalou; C Bile; D Yavo; E Boateng; S Z Wiktor; A E Greenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 7.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

8.  Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe.

Authors:  Kerina Duri; Fredrik Müller; Felicity Z Gumbo; Nyaradzai E Kurewa; Simba Rusakaniko; Mike Z Chirenje; Munyaradzi P Mapingure; Babill Stray-Pedersen
Journal:  BMC Infect Dis       Date:  2011-01-06       Impact factor: 3.090

Review 9.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17

Review 10.  Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview.

Authors:  Sello Lebohang Manoto; Masixole Lugongolo; Ureshnie Govender; Patience Mthunzi-Kufa
Journal:  Medicina (Kaunas)       Date:  2018-03-13       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.